Induction
Induction is the first and most intensive phase of treatment for acute leukemia. This topic explains its goal, how it goes and what to be prepared for.

01Short answer
02Simple explanation
Goal. Reduce leukemia cells as much as possible.
How? Several strong drugs together.
Where? Usually in hospital, for several weeks.
Then. The marrow is checked — is there remission?
03Scientific explanation
Principle: combining drugs with different mechanisms prevents resistance and reduces the leukemia burden by more than 99%, but hidden residual cells may remain — which is why consolidation is needed (NCI).
Assessing remission: complete remission means marrow blasts <5%, neutrophils ≥1.0×10⁹/L, platelets ≥100×10⁹/L and no leukemia outside the marrow. An MRD test shows how deep the remission is.
Complications: febrile neutropenia, inflammation of the mucous membranes (mucositis), tumour lysis syndrome, asparaginase-related clots and pancreatitis, and strain on the heart from anthracyclines. Teams watch for these with prevention and regular tests.
04What happens in the body?
The first days
A central venous catheter is often placed so that drugs can be given and blood taken without a new needle each time. Plenty of fluids and special medicines are given to prevent tumour lysis.
The low-count period
About a week after the course, blood counts reach their lowest point and may stay there for 2–4 weeks. During this time a fever is an emergency. As counts recover, strength returns.

Checking the result
At the end of induction a bone marrow test is done. If there is remission, consolidation begins. If not, the doctor may offer a second course or a different treatment.

05How induction goes
A simplified outline.







06Induction in AML and ALL (simplified)
| AML | ALL | |
|---|---|---|
| Typical drugs | Cytarabine + anthracycline ("7+3") | Steroid, vincristine, asparaginase ± anthracycline |
| Length | 7-day course, then recovery | 4–6 weeks |
| Targeted add-on | FLT3 inhibitor, gemtuzumab | TKI if Ph+ |
| CNS prevention | Usually not | Essential, intrathecal |
| Hospital | Often 3–5 weeks | Partly, by protocol |
| Check | Bone marrow, MRD | Bone marrow, MRD |
* Protocols differ; your doctor sets your plan.
07Key terms
- Induction
- The first treatment to reach remission.
- Remission
- Signs of leukemia disappearing.
- Neutropenia
- A shortage of neutrophils.
- Febrile neutropenia
- Fever during neutropenia — an emergency.
- Mucositis
- Inflammation of the mouth and gut lining.
- Central venous catheter
- A long tube placed in a large vein.
08Key points
- The goal of induction is remission.
- Drugs are given in combination.
- Blood counts fall sharply for a time.
- Fever is an emergency.
- The marrow is checked at the end.
- Consolidation follows remission.
09Frequently asked questions
Can I have visitors?
Healthy visitors are usually allowed; follow the hospital rules.
Will my hair fall out?
With many induction regimens, yes, usually temporarily.
What can I eat?
During neutropenia, follow food-safety rules (see topics “Handwashing: the simplest protection” and “Eggs and dairy: safe choices”).
Is a second course bad news?
Not always; some people reach remission after a second course.
10Questions for your doctor
Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.
Can I have visitors?
Will my hair fall out?
What can I eat?
Is a second course bad news?
12Sources
- National Cancer Institute (NCI). Adult Acute Myeloid Leukemia Treatment (PDQ) – Patient Version
- National Cancer Institute (NCI). Adult Acute Lymphoblastic Leukemia Treatment (PDQ) – Patient Version
- National Cancer Institute (NCI). Chemotherapy to Treat Cancer
- American Cancer Society. How Chemotherapy Drugs Work
- Cancer Research UK. Chemotherapy
- Blood Cancer United (LLS). Acute myeloid leukemia (AML) treatment: phases of treatment
- ICUsteps. Guide to intensive care: how might I feel
- Critical Care, 2010. Intensive care diaries reduce new onset post traumatic stress disorder following critical illness: a randomised, controlled trial
- MedlinePlus. Chronic Kidney Disease
- NIDDK (NIH). Kidney Disease